Literature DB >> 16782954

The management of severe sclerokeratitis following corneal transplantation surgery.

R Maini, J K G Dart.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16782954      PMCID: PMC1857148          DOI: 10.1136/bjo.2005.089789

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

1.  Use of cyclosporin in the treatment of steroid resistant post-keratoplasty atopic sclerokeratitis.

Authors:  M D Daniell; J K Dart; S Lightman
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.

Authors:  J Hori; J W Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-03       Impact factor: 4.799

3.  Surgically induced scleral necrosis.

Authors:  A Ramsay; J Dart
Journal:  Eye (Lond)       Date:  2000-06       Impact factor: 3.775

4.  New thoughts on the immunology of corneal transplantation.

Authors:  J W Streilein
Journal:  Eye (Lond)       Date:  2003-11       Impact factor: 3.775

5.  Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry.

Authors:  K A Williams; D Roder; A Esterman; S M Muehlberg; D J Coster
Journal:  Ophthalmology       Date:  1992-03       Impact factor: 12.079

6.  Sclerokeratitis after keratoplasty in atopy.

Authors:  C J Lyons; J K Dart; W A Aclimandos; S Lightman; R J Buckley
Journal:  Ophthalmology       Date:  1990-06       Impact factor: 12.079

7.  A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992.

Authors:  A S Bacon; D G Frazer; J K Dart; M Matheson; L A Ficker; P Wright
Journal:  Eye (Lond)       Date:  1993       Impact factor: 3.775

8.  Necrotizing scleritis after ocular surgery.

Authors:  A J Lyne; D Lloyd-Jones
Journal:  Trans Ophthalmol Soc U K       Date:  1979-04

9.  Surgically induced necrotising sclerokeratitis (SINS)--precipitating factors and response to treatment.

Authors:  E O'Donoghue; S Lightman; S Tuft; P Watson
Journal:  Br J Ophthalmol       Date:  1992-01       Impact factor: 4.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.